Aposense, GSK partner to study ML-10 PET tracer

06/8/2009 | AuntMinnie.com (free registration)

Molecular imaging firm Aposense and GlaxoSmithKline have teamed up to explore the potential of Aposense's ML-10 PET tracer in tracking drug activity during clinical trials of cancer medications. The two-year initiative will evaluate the tracer's ability to help fast-track the clinical development of cancer treatments.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Stryker
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD
Director, Office of Compliance
FDA, Center for Devices and Radiological Health
Silver Spring, MD